Sign up Australia
Proactive Investors - Run By Investors For Investors

Daily CryptoCann™ Report: Top economist thinks regulation will be the end of Bitcoin; WeedMD inks supply deal in British Columbia

Joseph Stiglitz, former chief economist of the World Bank, sees heavy regulation ahead for Bitcoin
Daily CryptoCann™ Report: Top economist thinks regulation will be the end of Bitcoin; WeedMD inks supply deal in British Columbia
As cryptocurrency continues to grow, it will be regulated to the point of being useless, Stiglitz says

The Crypto Report

Spain's Banco Santander SA (NYSE:SAN) is putting together a blockchain research team to explore the potential of applying the technology to securities trading.

Known as the “Digital Investment Banking” team, the group will look into the use of tokenized securities in debt capital markets, derivatives and other areas, as per a press release.

“The wave of digitalization that is occurring in the financial industry is accelerating. Our clients expect this to result in better solutions, lower costs and new categories of products and services that enable them to access capital markets more efficiently than ever before,” said José M. Linares, the bank’s head of corporate & investment banking in a statement.

Shares of the Madrid-based bank were up slightly to US$5.47 in Thursday afternoon trading.

READ: Daily CryptoCann™ Report: Walmart files a patent for blockchain delivery system; Michigan approves new conditions for its medicinal marijuana program

Back in the States, Nobel prize-winning economist Joseph Stiglitz had harsh words for cryptocurrency, forecasting heavy regulations going forward.

"If you open up a hole like bitcoin, then all the nefarious activity will go through that hole, and no government can allow that,” said Stiglitz in an interview with the Financial News.

Stiglitz, the former chief economist of the World Bank, predicts that as cryptocurrency continues to grow, it will be regulated to the point of being “useless.”

The price of Bitcoin is down slightly to US$6,192.18.

The Cann Report

WeedMD Inc (CVE:WMD) is continuing to expand alongside the Canadian cannabis market.

The Ontario-based cannabis company signed a supply deal with the British Columbia Liquor Distribution Brand.

"B.C. is widely recognized for having one of the most mature and developed cannabis consumer markets in Canada," said CEO Keith Merker.

The company recently inked deals with the Alberta Gaming, Liquor and Cannabis Commission as well as Shoppers Drug Mart, one of Canada’s largest pharmacy chains.

Shares of WeedMD were down slightly to C$1.70.

READ: WeedMD shares put on growth spurt as it inks new pot supply deal with British Columbia

In other news up North, medical marijuana company Sunniva Inc (CSE:SNN) is planning to spin off its Canadian assets into a separate Canadian asset to list on the Toronto Stock Exchange and the Nasdaq.

The multinational firm’s proposal includes Sunniva Medical and Natural Health Services, as per a press release.

Sunniva Medical is currently building a 740,000 square foot greenhouse facility in British Columbia. Canopy Growth Corp (NYSE:CGC) will buy 45% of its annual production capacity.

Natural Health Services operates a network of seven medical cannabis clinics.

Shares of Vancouver-based Sunniva were down slightly to C$7.89.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

Newswire
August 31 2018

Related Articles

cannabis
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
Kaneh Bosom Biotechnology: experienced management, access to capital and a clear strategy paves the
August 14 2018
The company says access to capital and a clear strategy will help it succeed

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use